medigraphic.com
ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana

2017, Number 6

<< Back Next >>

Rev ADM 2017; 74 (6)

Invasive and non-invasive tools for the diagnosis of oral cancer. Literature review

Pérez BHJ

Language: Spanish
References: 37
Page: 308-314
PDF size: 197.33 Kb.


ABSTRACT

Oral cancer is a neoplasm that is frequent on a worldwide level and is diagnosed late in at least 50-60% of the cases. Its late detection worsens the prognosis of patients because it is associated with a greater mortality. Therefore, it is essential to have tools that allow a timely diagnosis when premalignant lesions present and when there are no clinically identifiable premalignant lesions. In the present study, we review the invasive and non-invasive tools (modern and old) that have proven useful for the diagnosis of oral cancer; they are based both on techniques widely available in clinical practice and on techniques not yet available, but that could be implemented with appropriate coordination between the clinic professional and the researchers.


REFERENCES

  1. Bisen PS, Khan Z, Bundela S. Biology of oral cancer. Key apoptotic regulators. Boca Raton Florida, USA: CRC Press Taylor & Francis Group; 2014. p. 49.

  2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010; 60 (5): 277-300.

  3. Radhika T, Jeddy N, Nithya S, Muthumeenakshi RM. Salivary biomarkers in oral squamous cell carcinoma —An insight. J Oral Biol Craniofac Res. 2016; 6 (Suppl 1): S51-S54.

  4. Baykul T, Yilmaz HH, Aydin U, Aydin MA, Aksoy M, Yildirim D. Early diagnosis of oral cancer. J Int Med Res. 2010; 38 (3): 737-749.

  5. Chen GS, Chen CH. A study on survival rates of oral squamous cell carcinoma. Kaohsiung J Med Sci. 1996; 12 (6): 317-325.

  6. Sciubba JJ. Oral cancer. The importance of early diagnosis and treatment. Am J Clin Dermatol. 2001; 2 (4): 239-251.

  7. Mishra A, Verma M. Cancer biomarkers: are we ready for the prime time? Cancers (Basel). 2010; 2 (1): 190-208.

  8. Habis AH, Vernon SD, Lee DR, Verma M, Unger ER. Molecular quality of exfoliated cervical cells: implications for molecular epidemiology and biomarker discovery. Cancer Epidemiol Biomarkers Prev. 2004; 13 (3): 492-496.

  9. Wilder-Smith P, Osann K, Hanna N, El Abbadi N, Brenner M, Messadi D et al. In vivo multiphoton fluorescence imaging: a novel approach to oral malignancy. Lasers Surg Med. 2004; 35 (2): 96-103.

  10. Oliveira AP, Bitar RA, Silveira L, Zângaro RA, Martin AA. Near-infrared Raman spectroscopy for oral carcinoma diagnosis. Photomed Laser Surg. 2006; 24 (3): 348-353.

  11. Harris AT, Lungari A, Needham CJ, Smith SL, Lones MA, Fisher SE et al. Potential for Raman spectroscopy to provide cancer screening using a peripheral blood sample. Head Neck Oncol. 2009; 1: 34.

  12. Adeyemi BF, Kolude B. Clinical presentation of oral squamous cell carcinoma. Niger Postgrad Med J. 2013; 20 (2): 108-110.

  13. Vorvick LJ. No invasivo. Enciclopedia médica de la Biblioteca Nacional de Medicina de Estados Unidos de Norteamérica. Tomado de: https://medlineplus.gov/spanish/ency/article/002269.htm

  14. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med. 1993; 328 (3): 184-194.

  15. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002; 52 (4): 195-215.

  16. Scully C, Bagan JV, Hopper C, Epstein JB. Oral cancer: current and future diagnostic techniques. Am J Dent. 2008; 21 (4): 199-209.

  17. Ghalwash DM, El Gaaly K, Zahran FM, Shaker O, El-Fol HA. The diagnostic and prognostic value of salivary sCD44 level determination in oral malignant and potentially premalignant lesions. Advances in Environmental Biology. 2012; 6 (1): 302-310.

  18. Nagler RM, Barak M, Peled M, Ben-Aryeh H, Filatov M, Laufer D. Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma. Cancer. 1999; 85 (5): 1018-1025.

  19. Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res. 2008; 14 (19): 6246-6252.

  20. Gleber-Netto FO, Yakob M, Li F, Feng Z, Dai J, Kao HK et al. Salivary biomarkers for detection of oral squamous cell carcinoma in a Taiwanese population. Clin Cancer Res. 2016; 22 (13): 3340-3347.

  21. Brinkmann O, Kastratovic DA, Dimitrijevic MV, Konstantinovic VS, Jelovac DB, Antic J et al. Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population. Oral Oncol. 2011; 47 (1): 51-55.

  22. Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res. 2004; 10 (24): 8442-8450.

  23. Mizukawa N, Sugiyama K, Fukunaga J, Ueno T, Mishima K, Takagi S et al. Defensin-1, a peptide detected in the saliva of oral squamous cell carcinoma patients. Anticancer Res. 1998; 18 (6B): 4645-4649.

  24. Arellano-Garcia ME, Hu S, Wang J, Henson B, Zhou H, Chia D et al. Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Dis. 2008; 14 (8): 705-712.

  25. Connolly JM, Davies K, Kazakeviciute A, Wheatley AM, Dockery P, Keogh I et al. Non-invasive and label-free detection of oral squamous cell carcinoma using saliva surface-enhanced Raman spectroscopy and multivariate analysis. Nanomedicine. 2016; 12 (6): 1593-1601.

  26. Kurokawa H, Tsuru S, Okada M, Nakamura T, Kajiyama M. Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity. Int J Oral Maxillofac Surg. 1993; 22 (1): 35-38.

  27. Kurokawa H, Yamashita Y, Tokudome S, Kajiyama M. Combination assay for tumor markers in oral squamous cell carcinoma. J Oral Maxillofac Surg. 1997; 55 (9): 964-966.

  28. Krimmel M, Hoffmann J, Krimmel C, Cornelius CP, Schwenzer N. Relevance of SCC-Ag, CEA, CA 19.9 and CA 125 for diagnosis and follow-up in oral cancer. J Craniomaxillofac Surg. 1998; 26 (4): 243-248.

  29. Sakata J, Yoshida R, Matsuoka Y, Nagata M, Hirosue A, Kawahara K et al. Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia. Cancer Med. 2017; 6 (4): 730-738.

  30. Garnis C, Chari R, Buys TP, Zhang L, Ng RT, Rosin MP et al. Genomic imbalances in precancerous tissues signal oral cancer risk. Mol Cancer. 2009; 8: 50.

  31. Lajer CB, Nielsen FC, Friis-Hansen L, Norrild B, Borup R, Garnćs E et al. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br J Cancer. 2011; 104 (5): 830-840.

  32. Bhat S, Kabekkodu SP, Jayaprakash C, Radhakrishnan R, Ray S, Satyamoorthy K. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue. Virchows Arch. 2017; 470 (4): 445-454.

  33. El-Naggar AK, Mao L, Staerkel G, Coombes MM, Tucker SL, Luna MA et al. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn. 2001; 3 (4): 164-170.

  34. Sahu AK, Dhoot S, Singh A, Sawant SS, Nandakumar N, Talathi-Desai S et al. Oral cancer screening: serum Raman spectroscopic approach. J Biomed Opt. 2015; 20 (11): 115006.

  35. Bailey AM, Mao Y, Zeng J, Holla V, Johnson A, Brusco L et al. Implementation of biomarker-driven cancer therapy: existing tools and remaining gaps. Discov Med. 2014; 17 (92): 101-114.

  36. Bigler LR, Streckfus CF, Dubinsky WP. Salivary biomarkers for the detection of malignant tumors that are remote from the oral cavity. Clin Lab Med. 2009; 29 (1): 71-85.

  37. Beckman RA, Chen C. Efficient, adaptive clinical validation of predictive biomarkers in cancer therapeutic development. Adv Exp Med Biol. 2015; 867: 81-90.




2020     |     www.medigraphic.com